P04629 (NTRK1_HUMAN) Homo sapiens (Human)

High affinity nerve growth factor receptor UniProtKBInterProSTRINGInteractive Modelling

796 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

62 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
TrkA ECD complex with designed miniprotein ligand
7n3t
 Heteromer
36-382
1×NAG; 6×NAG; 5×EDO; 5×SO4;
Assess
Structure of the extracellular segment of human TRKA in complex with nerve growth factor
2ifg
 Heteromer
P01138; 		36-382
2×NAG; 4×NAG; 6×NAG;
Assess
NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR
1www
 Heteromer
P01138; 		282-382
Assess
SHC PTB DOMAIN COMPLEXED WITH A TRKA RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE
1shc
 Heteromer
P29353; 		489-500
Assess
TRK-A IN COMPLEX WITH LIGAND
6pme
homo-12-mer499-791
12×ZN; 12×OOY; 8×SRT;
Assess
Human TrkA in complex with the inhibitor AZ-23
4aoj
homo-12-mer500-791
12×V4Z; 24×ZN;
Assess
Crystal structure of TrkA kinase with ligand
6iqn
homo-2-mer502-790
2×AQ6;
Assess
Human Nerve growth factor receptor TrkA
1he7
homo-2-mer285-389
2×GOL;
Assess
TrkA transmembrane domain NMR structure in DPC micelles
2n90
homo-2-mer410-447
Assess
TrkA JM-kinase with 1-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea
5kml
monomer474-796
1×6UH;
Assess
TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea
5kmn
monomer474-796
1×6UK;
Assess
Crystal structure of Tyrosine-protein kinase receptor in complex with 2,4-dichloro-N-(3-methyl-1-ph…
6d1y
monomer481-796
1×FQJ;
Assess
Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-…
6d20
monomer482-796
1×FQD; 1×FQG;
Assess
Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-…
6d1z
monomer483-796
1×FQD; 1×GOL; 1×FQM;
Assess
Crystal Structure of TrkA kinase with ligand
5h3q
monomer484-796
1×7HF; 2×DTT; 1×NA;
Assess
TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(1-naphthyl)urea
5kmm
monomer484-796
1×6UJ;
Assess
TrkA JM-kinase with 2-fluoro-{N}-[2-(4-fluorophenyl)-6-methyl-3-pyridyl]-4-(trifluoromethyl)benzami…
5kmk
monomer484-796
1×6UG;
Assess
TrkA JM-kinase with 1-(9{H}-fluoren-9-yl)-3-(2-methyl-4-phenyl-pyrimidin-5-yl)urea
5kmi
monomer486-796
1×6UE;
Assess
TRK-A IN COMPLEX WITH LIGAND 6
6nss
monomer485-795
1×L0M;
Assess
TRK-A IN COMPLEX WITH LIGAND 1
6pl4
monomer485-795
1×OO7;
Assess
The crystal structure of TrkA(F589L) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-…
8j5w
monomer485-795
1×A4U;
Assess
TrkA JM-kinase with {N}-(2-pyridylmethyl)-2-[2-(2-thienyl)indol-1-yl]acetamide
5kmj
monomer486-795
1×6UF;
Assess
TRK-A IN COMPLEX WITH LIGAND 1
6npt
monomer491-795
1×KWY;
Assess
Crystal structure of Trk-A complexed with a selective inhibitor CH7057288
5wr7
monomer489-792
1×RCH;
Assess
The crystal structure of human TrkA kinase bound to the inhibitor
7xbi
monomer497-795
1×CVY; 1×CL;
Assess
The crystal structure of TrkA kinase in complex with 4^6,14-dimethyl-N-(3-(4-methyl-1H-imidazol-1-y…
7xaf
monomer498-796
1×FKT;
Assess
Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 19.
6dki
monomer500-796
1×22L; 1×GOD;
Assess
Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 13b.
6dkg
monomer500-796
1×22L; 1×GO7;
Assess
TRK-A IN COMPLEX WITH LIGAND 1a
6pl2
monomer499-795
1×OOM;
Assess
TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(2-pyridyl)urea
5kmo
monomer500-796
1×6UM;
Assess
The crystal structure of TrkA kinase in complex with 4^6-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-…
8j63
monomer500-796
1×A6X;
Assess
The crystal structure of TrkA kinase in complex with 4^6-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-…
8j61
monomer499-795
1×A0X;
Assess
TRK-A IN COMPLEX WITH LIGAND 1B
6pl1
monomer500-795
1×OOJ;
Assess
The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-…
8j5x
monomer500-795
1×A4U;
Assess
TRK-A IN COMPLEX WITH LIGAND 1a
6pmc
monomer500-795
1×OQJ;
Assess
TRK-A IN COMPLEX WITH LIGAND 9
6nsp
monomer500-795
1×L0P;
Assess
Crystal structure of the inactive TrkA kinase domain
4gt5
monomer498-793
Assess
TRK-A IN COMPLEX WITH LIGAND
6pma
monomer500-795
1×OQS;
Assess
Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10b.
6dkb
monomer501-796
1×FKY;
Assess
TRK-A IN COMPLEX WITH LIGAND 1a
6pmb
monomer500-795
1×OQM;
Assess
TRK-A IN COMPLEX WITH LIGAND 2a
6pl3
monomer500-795
1×OOD;
Assess
Crystal structure of TrkA (G595R) kinase domain
7vkm
monomer502-795
Assess
Crystal structure of Tyrosine-protein kinase receptor
6d22
monomer502-794
Assess
Crystal structure of TrkA (G595R) kinase with repotrectinib
7vkn
monomer502-794
1×7GI; 5×SO4;
Assess
Crystal structure of TrkA in complex with PF-05247452
5jfw
monomer502-793
1×6K2;
Assess
Crystal structure of TrkA in complex with PF-05206283
5jfv
monomer502-793
1×6K1;
Assess
Crystal structure of TrkA in complex with PF-06273340
5jfx
monomer502-793
1×6K4;
Assess
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK …
4yne
monomer502-793
1×4EK; 5×SO4; 1×GOL;
Assess
Crystal structure of TrkA in complex with PF-00593174
5jfs
monomer502-793
1×6K0;
Assess
Crystal structure of TrkA kinase with repotrectinib
7vko
monomer502-793
1×7GI; 5×SO4;
Assess
Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 3.
6dkw
monomer502-793
1×GXA;
Assess
Crystal structure of apo TrkA
4f0i
monomer501-790
Assess
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK …
4yps
monomer502-790
1×4F6; 4×SO4;
Assess
Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10e
6j5l
monomer502-790
1×B9C;
Assess
The structure of TrkA kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-…
4pmp
monomer501-787
1×31W; 1×CL; 3×ACT;
Assess
The structure of TrkA kinase bound to the inhibitor N-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)-2-{4…
4pmm
monomer501-787
1×31V; 1×GOL; 1×CL; 3×ACT;
Assess
The structure of TrkA kinase bound to the inhibitor N~4~-(4-morpholin-4-ylphenyl)-N~6~-(pyridin-3-y…
4pmt
monomer501-787
1×31Y; 1×CL; 3×ACT;
Assess
TrkA with (6~{R})-3-methylsulfanyl-6-phenyl-1-(1~{H}-pyrazol-3-yl)-6,7-dihydro-5~{H}-thieno[3,4-c]p…
5i8a
monomer501-787
1×69C; 1×CL; 3×ACT;
Assess
THE STRUCTURE OF TRKA KINASE DOMAIN BOUND TO THE INHIBITOR ENTRECTINIB
5kvt
monomer501-787
1×YMX; 1×GOL;
Assess
The structure of TrkA kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-…
4pms
monomer501-787
1×31X; 1×CL; 3×ACT;
Assess
NGF BINDING DOMAIN OF HUMAN TRKA RECEPTOR
1wwa
monomer282-386
Assess
Solution structure of a TrkAIg2 domain construct for use in drug discovery
4crp
monomer279-383
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5kml.1.Amonomer0.78474-796
100.00
Assess
2ifg.1.Amonomer0.6936-382
100.00
Assess

8 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25kml.1.Amonomer0.78468-790
100.00
Assess
Isoform 22ifg.1.Amonomer0.7036-382
100.00
Assess
Isoform 35kml.1.Amonomer0.78438-760
100.00
Assess
Isoform 32ifg.1.Amonomer0.6938-352
99.05
Assess
Isoform 45kml.1.Amonomer0.79376-698
100.00
Assess
Isoform 42ifg.1.Amonomer0.6636-290
1×NAG;99.61
Assess
Isoform 47n3t.1.Amonomer0.6536-290
94.05
Assess
Isoform 42ifg.1.Amonomer0.5343-282
77.73
Assess